Regulation of hepatic sulfotransferases by steroidal chemicals in rats

Drug Metabolism and Disposition

Volumn 24, Issue 8, 1996, Pages 854-858

  Liu, Lan ^a   Klaassen, Curtis D ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHOL; 16ALPHA CYANOPREGNENOLONE; BILE ACID; DEXAMETHASONE; DOPAMINE; ESTRONE; FLUORENYLACETOHYDROXAMIC ACID; LIVER ENZYME; MESSENGER RNA; PRASTERONE; STEROID; SULFOTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REGULATION; FEMALE; GENE EXPRESSION REGULATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER HOMOGENATE; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT;

ANIMALS; DEHYDROEPIANDROSTERONE; DEXAMETHASONE; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIVER; MALE; PREGNENOLONE CARBONITRILE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STEROIDS; SULFOTRANSFERASES;

ANIMALIA;

EID: 0029837230     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. G. J. Mulder and W. B. Jakoby: Sulfation. In "Conjugation Reaction in Drug Metabolism" (G. J. Mulder, ed.), pp. 107-161. Taylor & Francis Ltd., London, 1990.
2. J. R. DeBaun, E. C. Miller, and J. A. Miller: N-hydroxy-2-acetylaminofluorene sulfotransferase: its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver. Cancer Res. 30, 577-595 (1970).
3. T. Watabe, A. Hiratsuka, K. Ogura, and K. Endoh: A reactive hydroxymethyl sulfate ester formed regioselectively from the carcinogen, 7, 12-dihydroxymethylbenz-α-anthracene, by rat liver sulfotransferase. Biochem. Biophys. Res. Commun. 131, 694-699 (1985).
4. H. J. Kim, P. Rozman, C. Madhu, and C. D. Klaassen: Homeostasis of sulfate and 3′-phosphoadenosine 5′-phosphosulfate in rats after acetaminophen administration. J. Pharmacol. Exp. Ther. 261, 1015-1021 (1992).
5. Y. Yamazoe, K. Nagata, S. Ozawa, and R. Kato: Structural similarity and diversity of sulfotransferases. Chem.-Biol. Interact. 92, 107-117 (1994).
6. S. Ozawa, K. Nagata, D. W. Gong, Y. Yamazoe, and R. Kato: Expression and functional characterization of a rat sulfotransferase (ST1A1) cDNA for sulfations of phenolic substrates in COS-1 cells. Jpn. J. Pharmacol. 61, 153-156 (1993).
7. K. Nagata, S. Ozawa, M. Miyata, M. Shimada, D. W. Gong, Y. Yamazoe, and R. Kato: Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene. J. Biol. Chem. 268, 24720-24725 (1993).
8. W. F. Demyan, C. S. Song, D. S. Kim, S. Her, W. Gallwitz, T. R. Rao, M. Slomczynska, B. Chatterjee, and A. K. Roy: Estrogen sulfotransferase of the rat liver: complementary DNA cloning and age- and sex-specific regulation of messenger RNA. Mol. Endocrinol. 6, 589-597 (1992).
9. T. Watabe, K. Ogura, M. Satsukawa, H. Okuda, and A. Hiratsuka: Molecular cloning and functions of rat liver hydroxysteroid sulfotransferases catalyzing covalent binding of carcinogenic polycyclic arylmethanols to DNA. Chem.-Biol. Interact. 92, 87-105 (1994).
10. T. N. Thompson, J. B. Watkins, A. Gregus, and C. D. Klaassen: Effect of microsomal enzyme inducers on the soluble enzymes of hepatic phase II biotransformation Toxicol. Appl. Pharmacol. 66, 400-408 (1982).
11. A. Blanck, A. Astrom, and T. Hansson: Effects of neonatal and adult castration on the in vitro metabolism of steroids and xenobiotics in rat liver. Cancer Res. 46, 5072-5076 (1986).
12. S. A. Meyers, M. M. Lozon, J. D. Corombos, D. E. Saunders, K. Hunter, C. Christensen, and S. C. Brooks: Induction of porcine uterine estrogen sulfotransferase activity by progesterone. Biol. Reprod. 28, 1119-1128 (1983).
13. R. B. Kirkpatrick and P. G. Killenberg: Effects of ethinylestradiol on enzymes catalyzing bile acid conjugation and sulfation. J. Lipid Res. 21, 895-901 (1980).
14. T. P. Maus, R. K. Pearson, R. J. Anderson, L. C. Woodson, C. Reiter, and R. M. Weinshilboum: Rat phenol sulfotransferase: assay procedure, developmental changes, and glucocorticoid regulation. Biochem. Pharmacol. 31, 849-856 (1982).
15. N. A. Elshourbagy, J. L. Barwick, and P. S. Guzelian: Induction of cytochrome P450 by pregnenolone-16α-carbonitrile in primary monolayer cultures of adult rat hepatocyte and in a cell free translation system. J. Biol Chem. 256, 6060-6068 (1981).
16. D. M. Heuman, E. G. Schuetz, J. L. Barwick, N. A. Elshourbagy, and P. S. Guzelian: Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16α-carbonitrile or other steroidal or nonsteroidal agents. Mol. Pharmacol. 21, 753-760 (1982).
17. E. G. Schuetz, S. A. Wrighton, J. L. Barwick, and P. S. Guzelian: Induction of cytochrome P-450 by glucocorticoids in rat liver. J. Biol. Chem. 259, 1999-2006 (1984).
18. J. B. Watkins, Z. Gregus, T. N. Thompson, and C. D. Klaassen: Induction studies on the functional heterogeneity of rat liver UDP-glucuronosyltransferase. Toxicol. Appl. Pharmacol. 64, 439-446 (1982).
19. A. J. Sonderfan and A. Parkinson: Inhibition of steroid 5α-reductase and its effects on testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch. Biochem. Biophys. 265, 208-218 (1988).
20. M. P. Arlotto, A. J. Sonderfan, C. D. Klaassen, and A. Parkinson: Studies on the pregnenolone-16α-carbonitrile-inducible form of rat liver microsomal cytochrome P-450 and UDP-glucuronosyltransferase. Biochem. Pharmacol. 36, 3859-3866 (1987).
21. R. D. Sekura and W. B. Jakoby: Determination of aryl-sulfotransferase activity toward 2-naphthol. J. Biol. Chem. 254, 5658-5663 (1979).
22. N. R. Campbell, J. A. Van-Loon, R. S. Sundaram, M. M. Ames, C. Hansch, and R. Weinshilboum: Human and rat liver phenol sulfotransferase: structure-activity relationships for phenolic substrates. Mol. Pharmacol. 32, 813-819 (1987).
23. D. P. Ringer, D. Kampschmidt, R. L. King, Jr., S. Jackson, and D. E. Kifer: Rapid decrease in N-hydroxy-2-acetylaminofluorene sulfotransferase activity of liver cytosols from rats fed carcinogen. Biochem. Pharmacol. 32, 315-319 (1983).
24. J. B. Adams and A. Poulos: Enzymatic synthesis of steroid sulfates. III. Isolation and properties of estrogen sulphotransferase of bovine adrenal medulla. Biochim. Biophys. Acta 146, 493-508 (1967).
25. J. Rozhin, R. L. Soderstrom, and S. C. Brooks: Specificity studies on bovine adrenal estrogen sulfotransferase. J. Biol. Chem. 249, 2079-2087 (1974).
26. R. D. Sekura, C. J. Marcus, E. S. Lyon, and W. B. Jakoby: Assay of sulfotransferase. Anal. Biochem. 95, 82-86 (1979).
27. R. B. Kirkpatrick, N. M. Wildermann, and P. G. Killenberg: Androgens and estrogens affect hepatic bile acid sulfotransferase in male rats. Am. J. Physiol. 248, G639-G642 (1985).
28. S. Ozawa, K. Nagata, D. W. Gong, Y. Yamazoe, and R. Kato: Nucleotide sequence of a full-length cDNA (PST-1) for aryl sulfotransferase from rat liver. Nucleic Acids Res. 18, 4001 (1990).
29. K. Ogura, J. Kajita, H. Narihata, T. Watabe, S. Ozawa, K. Nagata, Y. Yamazoe, and R. Kato: Cloning and sequence analysis of a rat liver cDNA encoding hydroxysteroid sulfotransferase. Biochem. Biophys. Res. Commun. 165, 168-174 (1989).
30. K. Ogura, J. Kajita, H. Narihata, T. Watabe, S. Ozawa, K. Nagata, Y. Yamazoe, and R. Kato: cDNA cloning of the hydroxysteroid sulfotransferase STa sharing a strong homology in amino acid sequence with the senescence marker protein SMP-2 in rat livers. Biochem. Biophys. Res. Commun. 166, 1494-1500 (1990).
31. J. Littlewood, V. Glover, M. Sandler, R. Petty, and F. C. Rose: Platelet phenolsulfotransferase deficiency in dietary migraine. Lancet 1, 983-986 (1982).
32. S. Szabo: Effect of ACTH, corticoids and PCN (pregnenolone-16α-carbonitrile) on drug response and disposition. Acta Endocrinol. 230 (Suppl.), 1-112 (1979).
33. F. B. Jungalwala, O. Koul, A. Stoolmiller, and V. S. Sapirstein: Regulation of cerebroside and sulfatide metabolism in glia cells. J. Neurochem. 45, 191-198 (1985).
34. M. Runge-Morris and C. Vento: Effect of phenobarbital and dexamethasone treatment on rat liver hydroxysteroid sulfotransferase gene expression. FASEB J. 8, A1251 (abstr. X65) (1994).
35. M. Runge-Morris, C. Vento, and T. A. Kocarek: The effect of hormones on sulfotransferase gene expression in primary rat hepatocyte cultures. The Toxicologist 15, 55 (abstr. 294) (1995).
36. J. D. Beckmann, M. Illig, and R. Bartzatt: Regulation of phenol sulfotransferase expression in cultured bovine bronchial epithelial cells by hydrocortisone. J Cell Physiol. 160, 603-610 (1994).
37. S. J. Schauss, T. Henry, R. Palmetier, L. Halvorson, R. Dannenbring, and J. D. Beckmann: Characterization of bovine tracheobronchial phenol sulfotransferase cDNA and detection of mRNA regulation by cortisol. Biochem. J. 311, 209-217 (1995).
38. R. Weinshilboum: Sulfotransferase pharmacogenetics. Pharmacol. Ther. 45, 93-107 (1990).
39. R. A. Gilissen, D. P. Ringer, H. J. Stavenuiter, G. J. Mulder, and J. H. Meerman: Sulfation of hydroxylamines and hydroxamic acids in liver cytosol from male and female rats and purified aryl sulfotransferase IV. Carcinogenesis 13, 1699-1703 (1992).
40. D. P. Ringer and T. R. Norton: Further characterization of the ability of hepatocarcinogens to lower rat liver aryl sulfotransferase activity. Carcinogenesis 8, 1749-1752 (1987).
41. J. H. Meerman, C. Nijland, and G. J. Mulder: Sex differences in sulfation and glucuronidation of phenol, 4-nitrophenol and N-hydroxy-2-acetylaminofluorene in the rat in vivo. Biochem. Pharmacol. 36, 2605-2608 (1987).
42. D. P. Ringer, T. R. Norton, B. Cox, and B. A. Howell: Changes in rat liver N-hydroxy-2-acetylaminofluorene aryl sulfotransferase activity at early and late stages of hepatocarcinogenesis resulting from dietary administration of 2-acetylaminofluorene. Cancer Lett. 40, 247-255 (1988).